Oseni FDA Approved Drugs
OSENI [Alogliptin BenzoateC18H21N5O2C7H6O2 : Pioglitazone HydrochlorideC19H20N2O3SClH]
RX
- eq 12.5mg base : eq 15mg base (oral tablet)
eq 12.5mg base : eq 30mg base (oral tablet)
eq 12.5mg base : eq 45mg base (oral tablet)
eq 25mg base : eq 15mg base (oral tablet)
eq 25mg base : eq 30mg base (oral tablet)
eq 25mg base : eq 45mg base (oral tablet)
Takeda Pharms UsaJan 25, 2013
- Method of treating diabetes comprising administering a compound such as alogliptin.
- Method of treating diabetes comprising administering alogliptin.
- Methods of lowering elevated post prandial blood glucose levels comprising administering a dipeptidyl peptidase inhibitor.
- Methods of modifying glucose metabolism and treating diabetes comprising administering a dipeptidyl peptidase inhibitor and one or more other therapeutic agents such as metformin.
- Methods of reducing the side effects of active components administered to a diabetic patient comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering an insulin sensitivity enhancer such as pioglitazone in combination with an insulin secretion enhancer.
- Methods of treating diabetes comprising administering a dipeptidyl peptidase inhibitor and metformin.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.